IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 350 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,537,787 | 0.0% | 150,814 | 0.0% | 0.51% | +0.2% |
| Q1 2024 | $6,537,787 | -13.5% | 150,814 | +1.0% | 0.51% | -16.8% |
| Q4 2023 | $7,555,010 | +12.2% | 149,338 | +0.6% | 0.61% | +6.6% |
| Q3 2023 | $6,733,692 | +9.3% | 148,450 | -1.2% | 0.58% | +11.6% |
| Q2 2023 | $6,162,912 | +12.8% | 150,205 | -1.7% | 0.52% | +8.4% |
| Q1 2023 | $5,462,252 | -7.4% | 152,833 | -2.1% | 0.48% | -11.4% |
| Q4 2022 | $5,896,464 | +1.4% | 156,115 | -0.6% | 0.54% | -28.1% |
| Q3 2022 | $5,813,000 | +0.4% | 157,023 | +0.4% | 0.75% | +36.3% |
| Q2 2022 | $5,787,000 | -0.7% | 156,323 | -0.6% | 0.55% | -16.8% |
| Q1 2022 | $5,825,000 | +22.1% | 157,261 | +0.3% | 0.66% | +19.0% |
| Q4 2021 | $4,771,000 | – | 156,790 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |